Kaltura, Inc. KLTR Contingent Consideration Liability (Non-Current)

Contingent Consideration Liability (Non-Current) at other companies

Health CatalystHCAT

$156K-97.9%

ANI PharmaceuticalsANIP

$9.25M-46.9%

Steven MaddenSHOO

$15.27M+397%

BGSFBGSF

$249K-92.8%

TriSalus Life Sciences, Inc.TLSI

$2.74M-66.6%

KadantKAI

$2M—

Other financials

Income statement

See full

Revenue$44.6M-5.0%

Gross profit$32.1M-1.9%

Operating income-$1.2M+22.4%

Net income-$3.8M-237%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$58.5M+84.0%

Total debt$72.3M+49.0%

Total equity$4.6M-79.5%

Total assets$159.8M-7.5%

Cash flow

See full

Operating cash flow$656.0K+163%

CapEx$61.0K-79.5%

Free cash flow$595.0K+144%

Valuation

See full

Market cap$189.47M-37.1%

Enterprise value$203.31M-35.3%

P/S1.1×-0.6×

Profitability

See full

Gross margin71.2%+3.1pp

Operating margin-5.3%-2.1pp

Net margin-8.2%-1.9pp

FCF margin8.9%+2.4pp

Returns & leverage

See full

Return on equity-107.8%+28.3pp

Debt / equity15.6×+13.4×

Current ratio0.8×-0.3×

Where this comes from

Reported directly by Kaltura, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.

The official record: Kaltura, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kaltura, Inc.'s contingent consideration liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kaltura, Inc.'s contingent consideration liability (non-current)?: Kaltura, Inc. (KLTR) reported contingent consideration liability (non-current) of $6.81M in Q1 2026.